Clinical Trial: A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07425522) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)' on Feb. 16.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, Pharmacodynamics (PD), and Pharmacokinetics (PK) of multiple doses of RO7823653 in participants with DME, administered by intravitreal (IVT) injection as monotherapy and co-administered with faricimab.

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Diabetic Macular Edema

Intervention: DRUG: RO7823653

Participants will receive RO7823653 as an IVT injection per the schedu...